Categories
Tags
-
#health
#Report
#healthcare
#RootsAnalysis
#pharma
#Market
#Roots Analysis
#Healthcare Contract Manufacturing manufactures
#elastomeric
#manufacturing
#Peptides
#therapies
#medical
#Digital
#therapeutics
#drug
#molecules
#cell therapy
#nuclear
#polycystic
#vitro
#ophthalmic
#microbial
#synthetic
#drugs
#silco drug
#syringe
#reports
#biomarkers
#cancer
#molecule
#biologic
#silico
#RNAi
#vascular
#TIL-based
#protein
#degradation
#cell and gene therapy bioassay services
#cell and gene therapy bioassay
#Digital Health
#Digitization
#Diagnostics
#Monitoring
#DNA damage
#DDR Therapeutics
#DNA targeting
#PARP inhibitors
#Photodynamic therapy
#Photothermal therapy
#light therapy
#photoimmunotherapy
#Primary Packaging
#Vial
#Pre-Sterilized
#Cartridge
#pharmaceutical manufacturing
#pharma manufacturing
#CMO
#CDMO
#bioassay services
#bioassay market
#DNA damage response
#dna damage repair
Archives
Recent Entries
-
DESPITE OF AN EXHAUSTIVE MECHANISM OF DNA PROCESSING AND ITS HI
by Steffan JoeDNA damage can be referred to as any adverse alteration, which may occur in the form of base additions, base deletions or break in the sister DNA strands. Damage of genetic material is known to interfere with essential cellular processes, such as transcription and DNA replication. DNA lesions ... -
IN PURSUIT OF A COMPETITIVE EDGE, STAKEHOLDERS ARE ACTIVELY EXP
by Steffan JoeThe primary purpose of this analysis was to develop a deeper understanding of the overall strength of the contract service providers involved in this field. It allows companies to compare their existing capabilities within their respective peer groups and identify ways to gain a competitive edge in ... -
DIGITAL THERAPEUTICS – INCREASING REGULATORY SUPPORT HAS AIDED
by Steffan JoeDigital therapeutics are clinically validated applications / software / online programs that have demonstrated the capability to facilitate positive outcomes when used in the prevention / treatment / management of diseases / clinical conditions. These therapeutics are designed to engage patients in ... -
Light Activated Therapies Market: Focus on Photodynamic Therapi
by Steffan JoeTo order this 140+ page report, which features 80+ figures and 120+ tables, please visit https://www.rootsanalysis.com/reports/light-activated-therapies-market.html &n... -
PHARMACEUTICAL CONTRACT MANUFACTURING - CURRENT MARKET LANDSCAP
by Steffan JoeDuring our study, we were able to identify close to 500 players that are engaged in offering pharmaceutical contract manufacturing services. It is worth mentioning, most of the players (174) engaged in this domain offer contract manufacturing services for FDF / fill-finish operations, followed by th... -
PRE-STERILIZED / READY-TO-USE PRIMARY PACKAGING MARKET
by Steffan JoePrimary packaging, such as vials, syringes, and cartridges, and their affiliated closures, play a vital role in ensuring the stability, and sterility, and thereby, the overall quality, efficacy and safety of a drug product. Moreover, the packaging bears the product label, which provides information ... -
The targeted protein degradation enabling technologies market,
by Steffan JoeTargeted protein degradation has emerged as a revolutionary pharmacological concept that presents both viable and versatile drug development opportunities and is anticipated to introduce a new paradigm in modern healthcare London Roots Analysis has announced the addition of &ldquo... -
The TIL-based therapies market is projected to be worth over US
by Steffan JoeDriven by the potential to confer sustained therapeutic effects and thereby, facilitate prolonged periods of remission, TIL-based therapies have received significant financial support, and promising leads are poised to soon achieve blockbuster status Roots Analysis has announced the additio... -
The vascular disrupting agents market is projected to be worth
by Steffan JoeVascular disrupting agents (VDAs) are the novel oncology drugs being developed to more specifically combat complex, life threatening cancer indications London Roots Analysis has announced the addition of “Vascular Disrupting Agents Market, 2021-2030” report to its list ... -
The peptides and macrocycle drug discovery services market is e
by Steffan JoeGiven the recent developments in healthcare, supporting safety and efficacy of peptide and affiliated macrocycle drugs, the industry is presently witnessing an increase in discovery and development initiatives related to such therapeutic modalities. Roots Analysis has announced the addition... -
The RNAi therapeutics market is anticipated to grow at an annua
by Steffan JoeThe recent approval of first RNAi therapeutic, ONPATTROTM, has caused a surge in interest of the industry / non-industry players in upcoming field of pharmacological research London Roots Analysis has announced the addition of “RNAi Therapeutics Market (2nd Edition), 2019-20... -
Polycystic Ovary Syndrome Market, 2021-2031 by Roots Analysis
by Steffan JoeRoots Analysis is pleased to announce the publication of its recent study, titled, “Polycystic Ovary Syndrome Market, 2021-2031.” The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over t... -
Digital Health Market: Focus on Digital Therapeutics by Roots A
by Steffan JoeRecent advances in information technology and biomedical science have enabled the development of a number of versatile digital solutions that are capable of either mimicking or augmenting, the fundamental qualities of pharmacological interventions. Roots Analysis is pleased to announce the ... -
TIL-based Therapies Market, 2021-2030 by Roots Analysis
by Steffan JoeDriven by the potential to confer sustained therapeutic effects and thereby, facilitate prolonged periods of remission, TIL-based therapies have received significant financial support, and promising leads are poised to soon achieve blockbuster status Roots Analysis has announced the additio... -
Drug Repurposing Service Providers Market, 2020-2030 by roots a
by Steffan JoeTo order this detailed 250+ page report, please visit this - https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html Key Inclusions A detailed assessment of the current market landscape of companies offering drug repurposing services based on several relevant paramet... -
In silico drug revelation administrations market is probably go
by Steffan JoeOwing to their cost and time saving potential, in silico tools are widely used in modern pharmacological research; several companies have developed novel tools, which are specifically designed to accelerate and augment the drug discovery process. Roots Analysis has announced the ad... -
In excess of 35 industry players guarantee to offer administrat
by Steffan JoeDrug discovery is challenging and involves several complexities. In order to continue to add new molecules their pipelines, drug developers are opting to outsource such operations to contract research organizations (CROs). Outsourcing of peptides and macrocycle drug discovery has emerged as one of... -
The subcutaneous biologic drugs and affiliated technologies mar
by Steffan JoeRoots Analysis has done a detailed report on Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030 covering key aspects of the industry and identifying future growth opportunities To order this 530+ page report, which features 160+ figures and 190+ tables, ... -
The synthetic lethality-based drugs and targets market is proje
by Steffan JoeRoots Analysis has done a detailed study on “Synthetic Lethality-based Drugs and Targets Market, 2019-2030: Focus on DNA Repair (including PARP Inhibitors) and Other Novel Cellular Pathways” covering key aspects of the industry’s evolution and identifying potential future growth op... -
More than 85 small molecule protein degraders are currently bei
by Steffan JoeThe concept of targeted protein degradation presents revolutionary drug development opportunities and is anticipated to bring about a paradigm shift in modern healthcare. The first targeted protein degrader, called proteolysis targeting chimera (PROTAC), was developed about a decade ago. Presently, ... -
Cancer biomarkers market for TMB, MSI / MMR and TILs is estimat
by Steffan JoeAdvances in biotechnology have enabled the identification of several novel biomarkers, which are presently being used for a variety of purposes, including diagnosis, drug development, clinical research and to facilitate therapy-related decisions Roots Analysis is pleased to announce the pub... -
The blood-brain barrier (BBB) penetrating drugs market is estim
by Steffan JoeAdvances in biotechnology have enabled the development of versatile in vitro (static and dynamic), in vivo (micro-dialysis), and in situ (brain perfusion) blood–brain barrier models, allowing more effective and safe delivery of drugs across brain capillaries Roots Analysis is pleased ... -
The nuclear medicine and radiopharmaceutical manufacturing mark
by Steffan JoeThe recent surge in the demand of radiopharmaceuticals for diagnostic and therapeutic applications, coupled with the introduction of theranostics, has opened up opportunities for companies having capabilities to manufacture nuclear medicine and radiopharmaceuticals Roots Analysis is pleased... -
The synthetic lethality-based drugs and targets market is estim
by Steffan JoeAdvances in molecular screening technology have enabled the identification of novel synthetic lethal gene combinations, enabling the development of lead candidates that leverage the aforementioned phenomenon to offer therapeutic benefit. Roots Analysis is pleased to announce the publication... -
The targeted protein degradation market is projected to grow at
by Steffan JoeRoots Analysis has done a detailed study on Targeted Protein Degradation Market: Focus on Therapeutics and Technology Platforms (based on Degronimids, ENDTACs, Epichaperome Inhibitors, Hydrophobic Tags, IMiDs, LYTACs, Molecular Glues, PHOTACs, PROTACs, Protein Homeostatic Modulators, SARDs, SERDs, S...